5 BCBS plans back pharmacy startup
(By Nick Moran for Becker’s Hospital Review) Five Blue Cross Blue Shield plans are funding and collaborating with Evio, a
Read More(By Nick Moran for Becker’s Hospital Review) Five Blue Cross Blue Shield plans are funding and collaborating with Evio, a
Read More(By Ed Silverman for STAT) In 2016, a landmark report was issued on the global problem of antimicrobial resistance. The paper,
Read More(By Katie Adams for Becker’s Hospital Review) Biogen’s Alzeheimer’s drug Aduhelm could single-handedly represent 1 percent of all national healthcare
Read More(By Lauren Jensik for Becker’s Hospital Review) Brain cancer drug Gleostine is no longer available for coverage under Medicare Part
Read More(By Katie Adams for Becker’s Hospital Review) As more drugs enter the market with five-figure annual list prices, a large
Read MoreMedicare’s Open Enrollment starts October 15th, but it’s not too early to think about your Medicare coverage. During open enrollment,
Read More(By Andrew Joseph for STAT) Harry Johns is ready to stop talking about whether or not the Food and Drug
Read MoreThe COVID-19 pandemic has revealed a host of problems; among them was the realization that most pharmaceuticals are manufactured outside
Read More(By Elizabeth Cooney for STAT) Their phones are ringing off the hook and their email inboxes are filling up with
Read More(By Erica Carbajal for Becker’s Hospital Review) Now that about 43 percent of the U.S. population has been fully vaccinated,
Read More